Nuwellis (NUWE) Non Operating Interest Expenses (2015 - 2025)
Nuwellis' (NUWE) quarterly Non Operating Interest Expenses came in at -$46000.0 in Q1 2025, up 89.02% on a YoY basis from -$24335.9 in Q1 2024, and up 89.02% quarter-over-quarter from -$419000.0 in Q1 2024.
Powered by 
Analysis
Nuwellis (NUWE) Non Operating Interest Expenses (2015 - 2025) Analysis & Trends
Nuwellis (NUWE) has reported Non Operating Interest Expenses for 4 consecutive years, with -$46000.0 the latest figure, recorded in Q1 2025.
- For the quarter ending Q1 2025, Non Operating Interest Expenses rose 89.02% year-over-year to -$46000.0; the trailing twelve-month figure through Mar 2025 stood at -$397000.0 (down 13.43% YoY), and the FY2025 full-year result was $6.4 million, up 3524.29% from the prior year.
- Non Operating Interest Expenses grew to -$46000.0 in Q1 2025 per NUWE's latest filing, from -$419000.0 in the prior quarter.
- Across five years, Non Operating Interest Expenses topped out at -$46000.0 in Q1 2025 and bottomed at -$419000.0 in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 186.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 141.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 96.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -53.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -46,000.00 |
| Mar 31, 2024 | -419,000.00 |
| Sep 30, 2016 | 68,000.00 |
| Jun 30, 2016 | 1,000.00 |
| Mar 31, 2016 | 229,000.00 |
| Dec 31, 2015 | 245,000.00 |
| Sep 30, 2015 | 280,000.00 |
| Jun 30, 2015 | 155,000.00 |
| Mar 31, 2015 | 63,000.00 |